Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2 Purity >99.0% (HPLC) Telmisartan Intermediate Factory

Short Description:

Name: Methyl 2-[4-(Bromomethyl)phenyl]benzoate 

CAS: 114772-38-2

Purity: >99.0% (HPLC) 

Appearance: White to Light Yellow Crystalline Powder

Intermediate of Telmisartan (CAS: 144701-48-4)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name Methyl 2-[4-(Bromomethyl)phenyl]benzoate
Synonyms 2-[4-(Bromomethyl)phenyl]benzoic Acid Methyl Ester; Methyl 4'-(Bromomethyl)biphenyl-2-Carboxylate; 4'-(Bromomethyl)biphenyl-2-Carboxylic Acid Methyl Ester
CAS Number 114772-38-2
CAT Number RF-PI1879
Stock Status In Stock, Production Capacity 150MT/Year
Molecular Formula C15H13BrO2
Molecular Weight 305.17
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White to Light Yellow Crystalline Powder
Clarity Colorless and Transparent, Without Foreign Substances
Purity / Analysis Method >99.0% (HPLC)  
Melting Point 48.0~57.0℃
Loss on Drying <0.50%
Residue on Ignition <0.20%
Single Impurity <0.50%
Total Impurities <1.00% 
Heavy Metals (as Pb) <20ppm
Proton NMR Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Intermediate of Telmisartan (CAS: 144701-48-4)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

1

FAQ:

Application:

Methyl 2-[4-(Bromomethyl)phenyl]benzoate (CAS: 114772-38-2), pharmaceutical intermediates, used in the production of sartan series APIs. Methyl 2-[4-(Bromomethyl)phenyl]benzoate is an intermediate of Telmisartan (CAS: 144701-48-4). Telmisartan is an angiotensin II receptor blocker (ARB) that has high affinity for the angiotensin II receptor type 1 (AT1).Telmisartan interferes with the binding of angiotensin II to AT1 receptors in vascular smooth muscle and thus inhibits the vasoconstricting action of angiotensin II. Telmisartan was originally formulated by the German pharmaceutical company Boehringer Ingelheim. Telmisartan was launched in the US for the treatment of hypertension. Used alone or in combination with other classes of antihypertensives for the treatment of hypertension.

  • Write your message here and send it to us